---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-010518"
form_type: "8-K"
ticker: "TELO"
cik: "0001971532"
company_name: "Telomir Pharmaceuticals, Inc."
filed_at: "2025-05-15T23:59:59+00:00"
generated_at: "2026-05-21T06:00:11.201897+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Telomir identifies Telomir-Ag2, stabilized Silver(II) complex with broad-spectrum antibacterial activity

## Summary
- Telomir-Ag2 is a novel drug candidate from the proprietary Telomir-1 platform, stabilized Silver(II).
- Minimum Inhibitory Concentration (MIC) study shows broad-spectrum activity against Gram-positive and Gram-negative strains.
- Active against methicillin- and aminoglycoside-resistant Staphylococcus aureus (MARSA).
- Telomir-Ag2 exhibited greater antibacterial activity than the earlier Silver(I)-based Telomir-Ag1 formulation.
- Company plans formulation development and regulatory pathways targeting drug-resistant infections in burn wounds and post-surgical settings.

## SEC filing metadata
- accession: 0001641172-25-010518
- form_type: 8-K
- ticker: TELO
- cik: 0001971532
- company_name: Telomir Pharmaceuticals, Inc.
- filed_at: 2025-05-15T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971532/000164117225010518/0001641172-25-010518-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971532/000164117225010518/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-010518
- JSON: https://secwatch.observer/filing/0001641172-25-010518.json
- Plain text: https://secwatch.observer/filing/0001641172-25-010518.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.